跳至主要内容
临床试验/NCT05558241
NCT05558241进行中(未招募)不适用

Micro-UltraSound In Cancer - Active Surveillance (MUSIC-AS)

University of Alberta10 个研究点 分布在 4 个国家目标入组 210 人开始时间: 2022年11月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
210
试验地点
10
主要终点
Cancer upgrading during Active surveillance by micro-ultrasound and MRI

研究概览

简要总结

This study will compare the two imaging modalities (MRI and micro-ultrasound) during Active Surveillance of prostate cancer (PCa). Progression to clinically significant PCa will be assessed by first taking micro-US targeted samples (while blinded to MRI results), followed by MRI targeted samples, finishing with 12 systematic biopsy cores. The primary goal is to compare microUS to MRI for the detection of ≥GG2 PCa at confirmatory biopsy. This study will also collect blood samples from participants to be used for future biomarker studies.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Adult men with Gleason Grade Group 1 prostate cancer managed by active surveillance who require a confirmatory prostate biopsy

排除标准

  • Men who cannot undergo a prostate MRI
  • Men who cannot undergo a prostate biopsy

研究组 & 干预措施

Combined MRI and micro-ultrasound guided prostate biopsy.

Experimental

In a single biopsy session, first, a microUS-guided biopsy of regions of interest (ROIs) will be performed. The MRI fusion software will then be turned on, the clinician unblinded to the MRI results, and biopsy cores from within the boundaries of the MRI-fused lesion will be sampled from ROIs. Up to two ROIs identified on microUS or MRI will be targeted with up to 3 cores per ROI. If the MRI ROIs overlap with the microUS ROIs after unblinding, then the cores taken during the microUS-guided biopsy will be counted as both microUS and MRI-guided. Finally, a standard 12-core systematic biopsy will be performed.

干预措施: High-resolution micro-ultrasound (Device)

结局指标

主要结局

Cancer upgrading during Active surveillance by micro-ultrasound and MRI

时间窗: Immediately after biopsy.

The primary outcome will be detection of ≥Grade Group 2 by each biopsy, technique in combination with the systematic biopsy.

次要结局

  • Cancer upgrading during Active surveillance between imagine-guided versus systematic biopsy.(Immediately after biopsy.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验